FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to mammalogy, also aims at optimised therapy of palpable benign breast abnormalities. The patient is exposed to laser irradiation with a diode laser ensured by ultrasound-aided introduction of a light guide in an abnormality. Herewith, wavelength is 690-1270 nm, and power is 1.8-4.5 Wt. While irradiation, temperature is measured along the perimetre of a palpable abnormality with an acoustic metre. At temperature 42-55°C, the exposure is terminated. In fibrous adenoma, the exposure is terminated at temperature 50-55°C. For papillary cyst, temperature is 42-45°C.
EFFECT: method aims at high-grade restoration of organ structure and function by optimised therapy of palpable benign breast abnormalities.
3 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
SURGICAL METHOD FOR TREATING BENIGN NODULAR NEOPLASMS IN MAMMARY GLAND WITH HIGH INTENSITY LASER RADIATION | 2006 |
|
RU2319469C1 |
METHOD FOR ULTRASONIC EFFICIENCY CONTROL OF LASER DESTRUCTION OF BENIGN BREAST GROWTH | 2008 |
|
RU2385747C2 |
METHOD OF TREATING LACTOCELE | 2012 |
|
RU2493795C1 |
METHOD FOR COAGULATION AFTER VACUUM ASSISTED BIOPSY AND/OR REMOVAL OF BREAST NEOPLASMS USING LASER INTERSTITIAL RADIATION | 2021 |
|
RU2764353C2 |
METHOD FOR TREATING PATIENTS FOR NODAL FORMS OF THYROID GLAND DISEASES | 2004 |
|
RU2251991C1 |
METHOD OF TREATMENT OF CAVITARY FORMATIONS | 2016 |
|
RU2652750C1 |
THERAPY OF LACTEAL CYSTS | 2007 |
|
RU2356513C1 |
METHOD FOR TREATING TUMOR FORMATIONS BY APPLYING NONINVASIVE LASER SURGERY | 1998 |
|
RU2157709C2 |
METHOD OF TWO-STAGE COMBINED DESTRUCTION OF BENIGN THYROID NODULES | 2009 |
|
RU2402359C1 |
USE OF LASER INTERSTITIAL RADIATION FOR COAGULATION AND PREVENTION OF HEMATOMAS AFTER STEREOTACTIC VACUUM ASPIRATION BIOPSY | 2022 |
|
RU2817413C2 |
Authors
Dates
2010-02-20—Published
2008-08-25—Filed